General Information of the Compound
| Compound ID |
CP0572924
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(1S)-2-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2R)-2-(methanesulfonamido)-2-phenylacetyl]pyrrolidin-2-yl]-1,3-thiazol-5-yl]phenyl]phenyl]-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]methanesulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C44H44N6O6S4
|
||||||||||||||||||
| Molecular Weight |
881.14
|
||||||||||||||||||
| Canonical SMILES |
CS(=O)(=O)N[C@@H](C(=O)N1CCC[C@H]1c1ncc(s1)-c1ccc(cc1)-c1ccc(cc1)-c1cnc(s1)[C@@H]1CCCN1C(=O)[C@@H](NS(C)(=O)=O)c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C44H44N6O6S4/c1-59(53,54)47-39(33-11-5-3-6-12-33)43(51)49-25-9-15-35(49)41-45-27-37(57-41)31-21-17-29(18-22-31)30-19-23-32(24-20-30)38-28-46-42(58-38)36-16-10-26-50(36)44(52)40(48-60(2,55)56)34-13-7-4-8-14-34/h3-8,11-14,17-24,27-28,35-36,39-40,47-48H,9-10,15-16,25-26H2,1-2H3/t35-,36-,39-,40+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VIXDWXQVXWNJMD-DXPXTPKUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound